New implant aims to stop leakage in men

NCT ID NCT05547672

Ongoing Disease control Sponsor: UroMems SAS Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This early study tests a new artificial urinary sphincter device in 6 men with stress incontinence. The device is implanted to help control urine leakage. Researchers will check how many devices are successfully activated and how many need to be removed or revised within 6 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: UroMems artificial urinary sphincter device
What this could lead to: If successful, this could provide a new treatment option for men with stress urinary incontinence, potentially improving quality of life.
What could go wrong: This is a very early, small feasibility study with only 6 participants. The device may not work as expected or could require removal or revision. Results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for STRESS URINARY INCONTINENCE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

female stress incontinence Urinary Incontinence, Stress

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

URINARY INCONTINENCE,STRESS

Contacts and locations

Locations

CHU Nantes

Nantes, France
Groupe Hospitalier Pitié-Salpêtrière

Paris, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.